Supreme Court keeps broader access to abortion pill mifepristone in place while legal fight continues

The Supreme Court extended its administrative stay, blocking a lower court ruling that would restrict access to the abortion pill mifepristone, allowing telehealth prescribing and mail distribution to continue. The decision keeps current FDA rules in place, permitting patients to obtain mifepristone without an in-person doctor visit. The case stems from challenges to FDA changes expanding access to mifepristone.